Kenvue Inc. (KVUE) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health.
Total Cash From Operating Activities Chart for Kenvue Inc.
Kenvue Inc. (KVUE) operating cash flow for FY2025 was USD 2.2B, a 24.2% change from FY2024. Kenvue Inc.'s operating cash flow grew from USD 3.0B in 2019 to USD 2.2B in 2025 (-26.7% over 6 years). Operating cash flow compound annual growth rate: 5-year CAGR of -8.3%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $37.11B
- Implied Share Price
- $19.31
- Enterprise Value
- $44.41B
- Revenue (TTM)
- $15.53B
- EBITDA
- $3.51B
- Profit Margin
- 10.88%
- Trailing P/E
- 21.94
- Forward P/E
- 16.10
- Price/Book (MRQ)
- 3.65
- Price/Sales (TTM)
- 2.39
- EV/EBITDA
- 13.47
- EV/Revenue
- 2.86
- Dividend Yield
- 4.22%
- Book Value
- $5.29
- Free Cash Flow (FY2025)
- $1.72B
- Free Cash Flow Yield
- 4.64%
Snapshot as of 31st October 2026 — not point-in-time controlled, may lag the live market by a few days.